Clinical Trials Logo

Clinical Trial Summary

A Phase II, Multi-center, Randomized, Masked, Parallel-Control Study to Evaluate the Clinical Efficacy and Safety of IVIEW-1201 (1.0% PVP-Iodine) Gel Forming Ophthalmic Solution in the Treatment of Fungal Keratitis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06463678
Study type Interventional
Source IVIEW Therapeutics Inc.
Contact Qi Zhu, MD
Phone 617-431-7479
Email qzhu@iviewinc.com
Status Not yet recruiting
Phase Phase 2
Start date December 1, 2024
Completion date December 1, 2026

See also
  Status Clinical Trial Phase
Completed NCT02731638 - Mycotic Antimicrobial Localized Injection for Treatment of Corneal Ulcers Phase 3
Terminated NCT02088970 - Safety and Efficacity of Corneal Collagen Crosslinking in Infectious Keratitis (Bacterial and Fungal ): Randomized,Controlled, Prospective Study. (CXL) N/A
Completed NCT00557362 - Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer Phase 1/Phase 2
Completed NCT01831206 - Collagen Cross-linking in Infectious Keratitis Trial Phase 2
Terminated NCT00516399 - A Clinical Trial of the Treatment of Fungal Corneal Ulcers With Povidone-Iodine Phase 3
Completed NCT05655689 - The Antibiogram and Outcomes of Antimicrobial Regimens in Microbial Keratitis: A Prospective Cohort Study
Active, not recruiting NCT05110001 - Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction Phase 3